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Efficacy of Oral Administration of Sodium Iodide to Prevent Bovine
Respiratory Disease Complex
B.M. Shoemake , B.L. Vander Ley, B.W. Newcomer, and M.C. Heller
Background: The prevention of bovine respiratory disease complex (BRD) in beef cattle is important to maintaining
health and productivity of calves in feeding operations.
Objective: Determine whether BRD bacterial and viral pathogens are susceptible to the lactoperoxidase/hydrogen perox-
ide/iodide (LPO/H2O2/I
) system in vitro and to determine whether the oral administration of sodium iodide (NaI) could
achieve sufficient concentrations of iodine (I) in the respiratory secretions of weaned beef calves to inactivate these pathogens
in vivo.
Animals: Sixteen weaned, apparently healthy, commercial beef calves from the University of Missouri, College of Veteri-
nary Medicine teaching herd.
Methods: In vitro viral and bacterial assays were performed to determine susceptibility to the LPO/H2O2/I
 system at
varying concentrations of NaI. Sixteen randomly selected, healthy crossbred beef weanlings were administered 70 mg/kg NaI,
or water, orally in a blinded, placebo-controlled trial. Blood and nasal secretions were collected for 72 hours and analyzed
for I concentration.
Results: Bovine herpesvirus-1, parainfluenza-3, Mannheimia haemolytica and Bibersteinia trehalosi were all inactivated or
inhibited in vitro by the LPO/H2O2/I
 reaction. Oral administration of NaI caused a marked increase in nasal fluid I concen-
tration with a Cmax = 181 (1,420 lM I), T12, a sufficient concentration to inactivate these pathogens in vitro.
Conclusions and Clinical Importance: In vitro, the LPO/H2O2/I
 system inactivates and inhibits common pathogens asso-
ciated with BRD. The administration of oral NaI significantly increases the I concentration of nasal fluid indicating that this
system might be useful in preventing bovine respiratory infections.
Key words: Hypoiodous acid; Lactoperoxidase; Bovine respiratory disease; cattle.
Bovine respiratory disease complex (BRD) is a multi-factorial disease process that is currently thought to
be initiated by a stressful event, such as transport and
commingling of cattle, which results in immune
From the College of Veterinary Medicine, University of Missouri,
Columbia, MO (Shoemake); Great Plains Veterinary Educational
Center, University of Nebraska–Lincoln, Clay Center, NE (Vander
Ley); Department of Pathobiology, College of Veterinary Medicine,
Auburn University, Auburn, AL (Newcomer); Department of
Medicine and Epidemiology, School of Veterinary Medicine,
University of California, Davis, Davis, CA (Heller).
Work locations: The viral in vitro experiment was performed at
Auburn University College of Veterinary Medicine. The bacterial
in vitro experiment was performed at the University of California-
Davis College of Veterinary Medicine. The in vivo sodium iodide
experiment was performed at the University of Missouri College of
Veterinary Medicine.
Prior presentations: This research was presented as a research
abstract at the 2015 Conference of Research Workers of Animal
Diseases, and as a Research Report at 2016 ACVIM Forum,
Denver, CO.
Portions of this research and this manuscript were included in the
master’s thesis submitted by Dr. Brian Shoemake to the University
of Missouri.
Corresponding author: B.L. Vander Ley, Great Plains Veterinary
Educational Center, P.O. Box 148, Clay Center, NE 68933; e-mail:
bvanderley@gpvec.unl.edu
Submitted February 27, 2017; Revised September 8, 2017;
Accepted November 17, 2017.
Copyright © 2018 The Authors. Journal of Veterinary Internal
Medicine published by Wiley Periodicals, Inc. on behalf of the Ameri-
can College of Veterinary Internal Medicine.
This is an open access article under the terms of the Creative
Commons Attribution-NonCommercial License, which permits use,
distribution and reproduction in any medium, provided the original
work is properly cited and is not used for commercial purposes.
DOI: 10.1111/jvim.14903
Abbreviations:
lg micrograms
lM micromolar
ANOVA analysis of variance
ASL airway surface liquid
B. trehalosi Bibersteinia trehalosi
BHI brain heart infusion agar
BoHV1 bovine herpesvirus-1
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compromise and reduced resistance to infection. Com-
mingling of cattle also increases exposure to respiratory
pathogens. Subsequent viral infections compromise res-
piratory defenses that normally limit the migration of
pharyngeal flora into the lower respiratory tract. Bacte-
rial bronchopneumonia of the lungs causes pulmonary
damage compromising animal health and production.
Methods to decrease BRD and BRD-associated losses
include mitigating stress, preventing viral and bacterial
infections, and metaphylactic administration of antimi-
crobials. While these methodologies can reduce BRD,
they are often unsuccessful and require further antibi-
otic treatment of the bacterial bronchopneumonia.1
Concerns regarding antibiotic use continue to increase,
and alternative means of maintaining animal health and
welfare will be required as antibiotic use practices
evolve.
A novel approach to preventing and treating BRD
infections might be naturally present within the respira-
tory system. The upper respiratory tract utilizes innate
defense mechanisms to protect the respiratory system.
One component is an oxidative antimicrobial system in
the airway surface liquid (ASL), composed of hydrogen
peroxide (H2O2) produced by dual oxidase enzymes
(DUOX), lactoperoxidase (LPO) from epithelial submu-
cosal glands, and a halide/pseudohalide ion.2 Lactoper-
oxidase catalyzes a reaction of H2O2 with thiocyanate
(SCN), a pseudohalide secreted by the sodium iodide
(NaI) symporter found on the basolateral plasma mem-
brane, resulting in the formation of hypothiocyanite
(OSCN) within the ASL.2,3 The submucosal glands
required for this reaction are not present equally in all
mammals. Humans, sheep, and cattle have submucosal
glands, rats have few present, and smaller mammals
lack submucosal glands.2,4 A recent discovery in sheep
and humans is that the oxidative antimicrobial system
not only catalyzes SCN to OSCN but can also pro-
duce hypoiodous acid (HOI) from iodine (I). Hypoio-
dous acid is normally produced at negligible
concentrations because serum SCN concentration is
relatively greater than serum I concentration; therefore,
OSCN is preferentially formed. When I is supple-
mented as a single, high-dose bolus, iodide (I) secre-
tion in the upper respiratory tract increases. As I
concentration increases in the ASL, SCN concentra-
tion decreases, indicating that I and SCN compete
for secretion into the respiratory tract.2,3,5–7 Hypoio-
dous acid has potent antimicrobial activity.2 In in vitro
models, increasing I concentration in the LPO/H2O2/
I system to 500 lM results in a significant reduction in
viral pathogens.6 The administration of oral potassium
iodide (KI) resulted in ASL I concentration of
500 lM in humans. Thus, the oral administration of KI
was capable of providing I in the ASL at concentra-
tions high enough to achieve effective in vivo antimicro-
bial activity.6 The objectives of the presented study
were to determine whether the selected BRD pathogens
were susceptible to the oxidative antimicrobial system
composed of LPO/H2O2/I
 in vitro and determine
whether the oral administration of NaI could achieve
concentrations of I in the respiratory secretions of
weaned beef calves equivalent to those required to inac-
tivate these pathogens in vivo.
Materials and Methods
Viral In Vitro Susceptibility
The in vitro susceptibilities of BPI3V, BoHV1, and BVDV to
the LPO/H2O2/I
 reaction were tested using the following proce-
dure. All assays were performed in triplicate. The viral strains used
were TVMD60, Colorado, and 125C, respectively. The titer of the
stock virus for BPI3V and BoHV1 was 3.5 9 108 50% cell culture
infective dose (CCID50), and the beginning titer for the BVDV
stock concentration was 5.2 9 107 CCID50. In a 24-well plate,
minimum essential media were added (720–860 lL) to each reac-
tion well in the amount needed for a total reaction volume of
1,000 lL. Test assays were performed as previously described in
the following manner.6 NaI was added to each well to achieve a
final concentration of 0, 10, 100, or 250 lM NaI. Subsequently,
20 lg of LPO diluted to a concentration of 1 lg/lL in distilled
water was added to each well followed by the addition of 100 lL
of the appropriate stock virus solution. Finally, H2O2 was added
to achieve a final concentration of 100 lM. Each viral assay was
performed on a separate 24-well plate. Control reactions for LPO,
H2O2, and NaI individually, as well as negative and positive con-
trol wells, were included on each plate. Plates were incubated at
37°C for 5, 15, or 60 minutes and then frozen at 80°C for a min-
imum of 48 hours. Following a thaw cycle, virus titration of each
well was performed by direct observation of cytopathic effect in
cultured cells as previously described.8
Bacterial In Vitro Susceptibility
Bacterial isolates of Mannheimia haemolytica and Bibersteinia
trehalosi were obtained from clinical bovine pneumonia cases sub-
mitted to the California Animal Health and Food Safety Labora-
tory for necropsy. M. haemolytica and B. trehalosi were isolated
from submitted necropsy samples and replicated in vitro. Attempts
were made to assess P. multocida but it was not amenable to repli-
cation or consistent growth and thus was not utilized in this study.
Isolates were identified via traditional biochemical tests and con-
firmed via matrix-assisted laser desorption/ionization-time of flight
(MALDI-TOF) mass spectrometry. Identified isolates were stored
at 80°C in glycerol broth. For each experiment, an aliquot of
each isolate was subcultured to brain heart infusion agar (BHI)
and incubated overnight at 37°C. Isolated colonies from the BHI
agar plates were inoculated into 5 mL of BHI media and incu-
bated at 37°C and 250 rpm until log-phase growth was achieved.
Colony forming units (CFU) per mL of culture media were esti-
mated by optical density reading at 600 nm wave length, and
media were diluted to the desired concentration of 105 CFU/mL
for experimental treatments.
Experiments were carried out in deep well, 96-well plates.
Reagents were filter sterilized with 0.22-lm filter. Experimental
conditions were different than those of the viral assays and
included: NaI at concentration of 50, 100, 250, and 500 lM, LPO
(200 lg/mL), bacteria (105 CFU/mL), and H202 (100 lM). Con-
trol conditions included: NaI at concentrations stated above (50,
100, 250, and 500 lM) with bacteria alone; LPO with bacteria
alone; H202 with bacteria alone; phosphate-buffered saline (PBS)
with bacteria alone; and a negative control with all reagents but
without bacteria. A prereaction aliquot was taken for colony count
determination before adding H2O2 (starting titer); additional ali-
quots were collected 5 minutes (T5), and 30 minutes (T30) after
adding H2O2. Colony counts were determined using 10-fold serial
dilutions of each aliquot in sterile PBS, which were plated on BHI
Oral Iodine Bovine Respiratory Disease 517
agar, incubated overnight at 37°C, and quantified to calculate
CFU/mL. Experiments were carried out on each isolate in dupli-
cate and on 2 separate days.
Oral Sodium Iodide
Animals
Sixteen weaned commercial beef calves (average weight
270.5 kg  18.2 kg) were selected from the University of Missouri,
College of Veterinary Medicine teaching herd to be included in the
randomized, blinded, placebo-controlled study. The group con-
sisted of 4 steers and 12 heifers. The cattle were housed at the Col-
lege of Veterinary Medicine Middlebush Teaching Farm and
sample collection occurred through standard cattle processing
facilities on site. The calves were fed, watered, and cared for in
accordance with standard farm protocols. Animal use and meth-
ods were approved by the University of Missouri Animal Care
and Use Committee, protocol number 8207.
Calves were divided into 2 groups of 8 animals each, control
and treatment, by random number generator.a The 2 groups were
maintained in the same herd and pasture. Both primary investiga-
tors were blinded to treatment and control groups throughout the
study period. The treatment group was administered a single dose
of 70 mg/kg, 200 mg/mL (20%) NaIb by ororumen intubation.
The control group was administered an equivalent volume of
water by ororumen intubation.
Samples were collected immediately before administration of
treatments, T0, then every 12 hours for 72 hours. Samples col-
lected included blood and nasal secretions. Basic physical examina-
tion consisting of temperature, heart rate, respiratory rate, rumen
auscultation, and general visual inspection of the cattle was per-
formed at each sample collection. The calves were observed for
indications of iodine intoxication which included but are not lim-
ited to: salivation, diarrhea, excessive coughing, nasal discharge,
lacrimation, epiphora, alopecia, dermatitis, scaly hair coats, and
hyperthermia.9–11 Nasal fluid was collected from all calves by use
of a modified 1 mL serologic pipettec attached to a sample collec-
tion tubed and vacuum pump, as illustrated in Figure 1. Samples
were stored at 20°C until final processing on all samples could
be performed. Dithiothreitol (DTT)e was used to lyse the mucous
component of the ASL. This allowed for optimal iodine recovery
and successful sample analysis, similar to the method described by
Popov et al12 Blood samples were collected by jugular venipunc-
ture into 10 mL serum separator vacutainer blood tubes.d Blood
samples were centrifuged at 1,500 9 g for 30 minutes at 4°C. The
serum was removed and stored at 20°C until analysis. The nasal
fluid and serum were submitted to the Michigan State University
Diagnostic Center for Population and Animal Health and ana-
lyzed by inductively coupled plasma mass spectroscopy.
Data Analysis
In vitro viralf and bacterialg growth data were analyzed by 2-
way nonparametric ANOVA for time and treatment, with post
hoc testing. The concentration of iodineh measured in blood and
nasal secretions was analyzed by repeated measures ANOVA in
which the dependent variable was iodine concentration, and the
independent variable was the treatment group. Tukey’s post hoc
analysis was applied between groups and treatment time points.
Results
Viral In Vitro Susceptibility
Viral titers for BPI3V were significantly decreased
(P = 0.001) in all reactions containing even the lowest
concentration of NaI, Figure 2. The reaction containing
10 lM NaI decreased the average viral titer by 2 logs
compared to the positive control wells; the 100 lM
reaction further reduced the mean titer by an additional
2 logs. The virus was completely inhibited in all wells
containing a NaI concentration of 250 lM regardless of
the presence of LPO or H2O2. However, the differences
in inhibition between the various NaI concentrations
were not statistically different. For BoHV1, significant
reduction in viral titer was seen at reactions containing
>10 lM NaI (P < 0.001). At the 100 lM NaI concen-
tration, the mean viral titer decreased 4 logs compared
to the positive control wells, Figure 3. As with BPI3V,
a NaI concentration of 250 lM completely inactivated
the virus, regardless of the presence of LPO or H2O2.
Of the 3 viruses, BVDV showed the least susceptibility
to the system with no observed differences (P = 0.33) in
titer at even the highest concentrations of NaI,
Figure 4. Titers of BPI3V (P = 0.44), BoHV1
(P = 0.14), and BVDV (P = 0.65) were not affected by
incubation time.
Bacterial In Vitro Susceptibility
At all concentrations of NaI in combination with
LPO and H202, growth of both M. haemolytica and
B. trehalosi was inhibited by the complete reaction by
5 minutes after the reaction was started (T5), Figures 5
and 6. There was no significant difference between bac-
terial numbers at T0 for any of the treatment condi-
tions, aside from the negative control. A 2-way
ANOVA of results for M. haemolytica was significant
for time (P < 0.0001), treatment (P < 0.0001), and
interaction of time and treatment (P = 0.0008). Post
hoc pairwise comparisons revealed significantly
decreased bacterial counts at T5 in all 3 NaI concentra-
tions (50, 100, and 500 lM) that included H2O2 and
LPO compared to the positive control. Results for
Fig 1. Nasal suction device. A 1 mL serologic pipette that was
heat flared at the proximal aspect to create a smooth suction sur-
face. Two, 90° bends were placed in the length of the pipette to
allow for ease of handling of the device. The distal aspect of the
pipette was placed through the rubber tube stopper of a red top
serologic tube. A 16-gauge needle attached to a vacuum line and
vacuum source was then inserted into the same rubber tube
stopper.
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B. trehalosi were similar; a 2-way ANOVA showed sig-
nificant effect of time (P < 0.0001) and treatment
(P < 0.0001); however, effect of interaction of time and
treatment was not significant (P = 0.69). NaI alone at
higher concentrations (100 and 500 lM) inactivated
both bacterial pathogens in vitro, in the absence of
LPO and H2O2; however, this trend was not statistically
significant. Failure to show significance is likely due to
variability in bacterial counts of control conditions.
In Vitro Sodium Iodide Animal Model
Serum Iodine Concentration
Both groups had no significant difference in serum I
concentrations at T0 with an average of 0.04 mg/L
(0.3 lM) and 95% confidence interval (CI) of 0.03–
0.05 mg/L. After NaI administration, the serum I con-
centrations were significantly increased (P < 0.05) at
each collection time point beginning with T12 through
the final collection time point of T72 post-NaI adminis-
tration, as depicted in Figure 7. The highest measured
average serum I concentration at T12 was 106 mg/L
(834 lM) and CI of 92–120 mg/L; subsequently, serum
I concentration steadily declined during the remainder
of the study period. During the 72-hour study period,
at each collection time point, the control group did not
have a significant change in serum I concentration.
Nasal Secretion Iodine Concentration
Both groups had similar average I concentrations at T0
in nasal secretions: control 0.915 mg/L (7.21 lM), CI of
Fig 2. Bovine parainfluenza-3 virus. Presented are the experimental conditions of Bovine PI-3 virus: LPO, H2O2, and a concentration of
NaI (10, 100, or 250 lM NaI), as depicted by the solid bars. The control conditions, represented by the checked and dashed bars, include
virus only, LPO only, H2O2 only, NaI (250 lM) only, and media only. Standard error bars presented. BPI3V was significantly inhibited at
all concentrations of NaI but no effect of time was detected.
Fig 3. Bovine herpesvirus-1. Presented are the experimental conditions of BHV-1 virus: LPO, H2O2, and a concentration of NaI (10, 100,
or 250 lM NaI), as depicted by the solid bars. The control conditions, represented by the checked and dashed bars, include virus only,
LPO only, H2O2 only, NaI (250 lM) only, and media only. Standard error bars presented. BoHV1 was significantly inhibited at concentra-
tions of NaI >10 lM but no effect of time was detected.
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0.067–1.76 mg/L, and treatment 0.529 mg/L (4.17 lM),
CI of 0.185–0.873 mg/L. The concentration of I in the
nasal secretions was significantly increased (P < 0.05)
after the administration of a NaI oral bolus as demon-
strated in Figure 8. At the T12 sample collection time
point, the treatment group had a significantly higher
average I concentration of 181 mg/L (1,420 lM) and CI
of 155–206 mg/L in the nasal secretions that remained
significantly different throughout the 72-hour study per-
iod of the treatment group. The I concentration of nasal
secretions steadily declined during the study period. The
control group nasal secretion I concentration did not
change throughout the study period.
Physical Examination
Physical examination findings for temperature and res-
piratory rates between the 2 study groups were not statis-
tically different. At the T0 and T48, the heart rates of the
control group were significantly greater than the treat-
ment group, 166 beats per minute and 145 beats per
minute, respectively. Throughout the study period, evi-
dence of I toxicity was not observed during routine phys-
ical examinations and sample collection. Herd caretakers
Fig 4. Bovine Viral Diarrhea Virus. Presented are the experimental conditions of BVDV: LPO, H2O2, and a concentration of NaI (10,
100, or 250 lM NaI), as depicted by the solid bars. The control conditions, represented by the checked and dashed bars, include virus
only, LPO only, H2O2 only, NaI (250 lM) only, and media only. Standard error bars presented. No significant effect of treatment on
BVDV titers was detected.
Fig 5. Mannheimia haemolytica. Presented are the experimental conditions of M. haemolytica, LPO, H2O2, and a concentration of NaI (0,
50, 100, or 500 lM NaI), depicted by the solid bars. The control conditions, represented by the checked and dashed bars, include PBS and
M. haemolytica; NaI alone at 50, 100, or 500 lM concentrations and M. haemolytica; LPO and M. haemolytica; H2O2 and M. haemolytica;
and LPO, H2O2, 100 lL NaI, and no M. haemolytica. Standard error bars presented. All treatments except for 0 lM NaI achieved statisti-
cally significant differences at T5. Statistical significance could not be achieved at T30 despite lack of bacterial growth in culture in all exper-
imental reactions except for 0 lM NaI.
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did not indicate concerns of any health abnormalities
during or immediately after the study period.
Discussion
The results of the experiments presented in this report
demonstrate that the LPO/H2O2/I
 system inactivates
BoHV1, BPI3V, M. haemolytica, and B. trehalosi
in vitro. This study also demonstrated that weanling
beef calves are capable of secreting I in the upper respi-
ratory tract after a single bolus of oral NaI. While more
investigation into the application of these findings is
required, the use of a single oral bolus of NaI might be
a new methodology in the prevention or mitigation of
BRD.
The one pathogen that was not found to be suscepti-
ble to inactivation by the LPO/H2O2/I
 system was
BVDV, which is a member of the Flaviviridae family
and of the genus Pestivirus. It is a single-stranded
RNA, nonsegmented, enveloped virus with 2 biotypes
that can cause immunosuppression.13,14 The reason for
this difference in susceptibility to the LPO/H2O2/I
 is
unknown. One consideration might be that BVDV is
fairly hardy in the environment and is resistant to most
disinfectants and environmental conditions.13 If this is
the case, a higher concentration of NaI might be
required to inactivate BVDV. The importance of
BVDV’s lack of inactivation by the LPO/H2O2/I
 sys-
tem will require further investigation.
Bovine respiratory syncytial virus (BRSV) is another
important viral pathogen of BRD. Because of its simi-
larity to human respiratory syncytial virus (hRSV),
BRSV was not examined in this study. BRSV was not
examined in vitro in this study because of the previous
reports of inactivation of hRSV in both in vitro studies
and an in vivo challenge model in sheep of the LPO/
H2O2/I
.2,6 In the in vivo challenge model, lambs
administered KI had decreased gross pulmonary lesions,
viral antigen concentration, and clinical signs of
respiratory disease compared to controls.2 Human
respiratory syncytial virus and BRSV are remarkably
similar, to the extent that BRSV has been used as an
animal model for hRSV studies.15–17 Another limitation
of this study was that the calves utilized were not
stressed or commingled immediately before the onset of
the study period. Commingling and stress are known
factors of BRD’s pathogenesis. Extrapolating these
results to stressed and/or commingled calves might be
premature.
This study determined that beef weanlings are cap-
able of secreting I in the upper respiratory tract after a
single bolus of oral NaI. The highest measured nasal I
concentration was 181 mg/L (1,420 lM). Based on the
in vitro data, this concentration of iodine could inacti-
vate BoHV1 and BPI3V and inhibit M. haemolytica
and B. trehalosi in vivo. These results are similar to
those previously reported in both humans and sheep.2,6
In previous studies, HOI was measured directly. In
the present study, the presence of I was measured as
inorganic I as a proxy measurement of HOI in the
nasal secretions of calves, as previously reported.6
Hypoiodous acid is formed by the reaction of H2O2
and I (catalyzed by LPO oxidation) identically to
OSCN formation. Compared to OSCN, HOI is con-
siderably virucidal as well as antibacterial. In ovine
models, both respiratory syncytial virus and adenovirus
were rapidly inactivated by HOI.2 The proposed mecha-
nism of action of HOI is that it modifies the surface
proteins of the virus.6 These changes can inhibit binding
and/or entry of the virus into the host cells. This is
achieved through the oxidation of sulfhydryl groups,
unsaturated double bonds, and iron-sulfur centers.18,19
A concern of any modified cellular process is whether
the new output or reaction will result in cytotoxicity.
By measuring lactate dehydrogenase, it has been deter-
mined that HOI is not cytotoxic. This was demon-
strated by the application of LPO, H2O2, and NaI to
well-differentiated epithelial cells in vitro. Based on
these findings, HOI is a potent antimicrobial but does
not damage the respiratory epithelium.2,6
Fig 6. Bibersteinia trehalosi. Presented are the experimental conditions of B. trehalosi, LPO, H2O2, and a concentration of NaI (0, 50,
100, or 500 lM NaI), depicted by the solid bars. The control conditions, represented by the checked and dashed bars, include PBS and
B. trehalosi; NaI alone at 50, 100, or 500 lM concentrations and B. trehalosi; LPO and B. trehalosi; H2O2 and B. trehalosi; and LPO,
H2O2, 100 lL NaI, and no B. trehalosi. Standard error bars presented. Statistical significance of time and treatment was achieved in all
reactions except 0 lM NaI. Bacterial growth did not occur in all experimental reactions expect for 0 lM NaI test conditions.
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NaI has been used for the treatment of various infec-
tious diseases in cattle since the beginning of the last
century. Traditionally, NaI is administered as an
intravenous bolus at a dose of 70 mg/kg. Signs of I
intoxication can be observed at this dose, especially
when multiple doses are administered for treatment.
Fig 7. The serum iodine concentration of treatment (NaI, n = 8) and control (water, n = 8) groups. At T0, grouping markers (darkened
circle and triangle) overlapping. The highest measured concentration of iodine was 106 mg/L. Standard error of the mean bars graphed.
* indicates statistically significant difference at P < 0.05.
Fig 8. The concentration iodine in nasal secretions treatment (NaI, n = 8) and control (water, n = 8) groups. At T0, grouping markers
(darkened circle and triangle) overlapping. The highest measured concentration of iodine was 181 mg/L. Standard error of the mean bars
graphed. * indicates statistically significant difference at P < 0.05.
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These signs include any degree or combination of the
following: anorexia, salivation, diarrhea, excessive
coughing, nasal discharge, pneumonia, lacrimation, epi-
phora, alopecia, dermatitis, scaly hair coats, and hyper-
thermia. Iodine toxicity usually resolves when the I
source is removed, and clinical signs diminish over a
period of 2–3 days without long-term affects.9–11
When considering an antimicrobial for administration
in food animals, the effect on the animal and consum-
able product must be acknowledged. First and foremost
is the effect the treatment has on the animal’s health. In
this study, there were no clinical signs or measurable
abnormalities as a result of the administration of oral
NaI at the dose administered. The only significant
change between the 2 treatment groups was the heart
rates at T0 and T48 when the treatment group heart
rates were statistically significantly lower than the con-
trol, 166 beats per minute and 145 beats per minute,
respectively. Both of these values are greater than the
standard heart rates of cattle. However, these heart
rates were taken immediately upon entry to the process-
ing chute and are likely attributable to physiological
responses associated with handling. Secondly, there is
concern as to the effect on the consumable tissues and
potential harmful residues. Iodine toxicity of humans
through food animal sources could present a potential
risk to human health. Most of the soil throughout the
world is considered I deficient.9 Currently, table salt is
iodized to help prevent the occurrence of I deficiency in
people.20 Recent investigations into the I content of
food products determined that beef is not a pertinent
source of I to humans (<2% of requirements), even
when the animal is fed chronic doses above natural
homeostatic requirements.21
In conclusion, LPO/H2O2/I
 is capable of inactivating
BoHV1 and BPI3V and inhibiting the growth of
M. haemolytica and B. trehalosi based on the in vitro
analyses performed. By reducing these viral and bacterial
pathogens, the morbidity and mortality of BRD might
effectively be reduced. Weanling beef calves are capable
of secreting I in their upper respiratory tract after admin-
istration of a one-time oral bolus of NaI at 70 mg/kg.
Further investigation of the application of oral NaI
treatment as a prevention of BRD is warranted.
Footnotes
a Excel, Microsoft Corp., Redmond, WA
b Nova Tech, Inc, Grand Island, NE
c Celltreat Scientific Products, Shirley, MA
d Becton, Dickinson and Company, Franklin Lakes, NJ
e EMD Millipore Corp., Billerica, MA
f JMP Pro 13.0, SAS institute, Inc, Cary, NC
g GraphPad Prism 6, GraphPad Software, Inc, La Jolla, CA
h StataCorp LP, College Station, TX
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